| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.005 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.007 |